Merck Aktie
113,20
EUR
-2,90
EUR
-2,50
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| DZ BANK | - | - | 01.04.2025 | |
| UBS AG | 180,00 EUR | +55,84% | 12.03.2025 | |
| Goldman Sachs Group Inc. | 177,00 EUR | +53,25% | 11.03.2025 | |
| Deutsche Bank AG | 174,00 EUR | +50,65% | 07.03.2025 | |
| JP Morgan Chase & Co. | 190,00 EUR | +64,50% | 07.03.2025 | |
| Bernstein Research | 168,00 EUR | +45,45% | 06.03.2025 | |
| Jefferies & Company Inc. | 180,00 EUR | +55,84% | 14.11.2024 | |
| Barclays Capital | 195,00 EUR | +68,83% | 01.08.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 139,66 GBP | +38,88% |
| BASF | 5 | 4 | 2 | 53,56 EUR | +28,97% |
| Bayer | 1 | 8 | 0 | 24,88 EUR | +25,19% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 8 | 1 | 2 | 145,80 EUR | +27,89% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +37,34% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 1 | 16,62 GBP | +24,82% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 3 | 5 | 2 | 386,50 EUR | +13,94% |
| LANXESS AG | 4 | 3 | 3 | 28,50 EUR | +31,09% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 180,57 EUR | +56,34% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +14,50% |
| Pfizer Inc. | 3 | 3 | 0 | 30,20 USD | +33,45% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Reckitt Benckiser Plc | 2 | 7 | 0 | 56,22 GBP | +18,46% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 3 | 0 | 115,50 EUR | +23,81% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,34 GBP | +8,02% |
| WACKER CHEMIE AG | 6 | 2 | 0 | 96,86 EUR | +63,06% |